PRESS RELEASE published on 04/01/2026 at 17:48, 3 months 29 days ago HBM Healthcare Investments increases NAV by 17.2 percent and expects annual profit of CHF 272 million for the 2025/2026 financial year HBM Healthcare Investments AG reports a 17.2% increase in NAV and anticipates a CHF 272 million annual profit for the 2025/2026 financial year, driven by positive transactions and market conditions Healthcare Sector HBM Healthcare Investments NAV Increase Annual Profit 2025/2026
PRESS RELEASE published on 04/01/2026 at 17:47, 3 months 29 days ago Key Figures 31.03.2026 HBM Healthcare Investments AG reports key figures as of 31.03.2026 in CHF. Monthly performance percentages for NAV and share price provided Performance HBM Healthcare Investments AG Key Figures CHF 31.03.2026
BRIEF published on 03/25/2026 at 14:33, 4 months 5 days ago Merck to Acquire Terns Pharmaceuticals from HBM for $6.7 Billion Merck HBM Healthcare Pharmaceutical Acquisition Oncology Therapy Terns Pharmaceuticals
PRESS RELEASE published on 03/25/2026 at 14:28, 4 months 5 days ago Merck to Acquire HBM Portfolio Company Terns Pharmaceuticals for USD 6.7 Billion Merck to acquire Terns Pharmaceuticals, a clinical-stage oncology company, from HBM Healthcare Investments for USD 6.7 billion. The acquisition highlights the demand for innovative therapies Acquisition Oncology Merck Innovative Therapies Terns Pharmaceuticals
BRIEF published on 03/16/2026 at 17:52, 4 months 14 days ago HBM Healthcare Investments AG Reports March Key Figures Financial Performance Net Asset Value Share Price Investment Analysis HBM Healthcare
PRESS RELEASE published on 03/16/2026 at 17:47, 4 months 14 days ago Key Figures 15.03.2026 HBM Healthcare Investments AG releases key performance figures for March 15, 2026, showing fluctuations in NAV and share price Performance HBM Healthcare Investments AG Key Figures Share Price NAV
BRIEF published on 03/02/2026 at 17:52, 4 months 28 days ago HBM Healthcare Investments AG Reports Monthly Performance Figures Financial Report Share Price NAV HBM Healthcare Performance Metrics
PRESS RELEASE published on 03/02/2026 at 17:47, 4 months 28 days ago Key Figures 28.02.2026 HBM Healthcare Investments AG reports key figures for February 2026, with NAV at 275.58 CHF and Share Price at 222.00 CHF. Performance percentages shown HBM Healthcare Investments AG Key Figures Share Price NAV February 2026
BRIEF published on 02/16/2026 at 17:51, 5 months 14 days ago HBM Healthcare Reports February 2026 Financial Performance Financial Figures Share Price NAV HBM Healthcare February 2026
PRESS RELEASE published on 02/16/2026 at 17:46, 5 months 14 days ago Key Figures 15.02.2026 HBM Healthcare Investments AG reported key figures for 15.02.2026, showing performance in CHF. NAV at 272.51, Share Price at 220.00, and Total Net Assets at 1'806 million Performance HBM Healthcare Investments AG Key Figures CHF 15.02.2026
Published on 07/31/2026 at 08:00, 2 minutes ago Caledonia Mining Corporation Plc Notification of Relevant Change to Significant Shareholder
Published on 07/31/2026 at 01:39, 6 hours 23 minutes ago Transition from OTCQB to Unsponsored OTC Quotation
Published on 07/30/2026 at 23:45, 8 hours 17 minutes ago Namibia Critical Metals Announces Completion of Japan's C$23 Million Earn-In and Formation of Strategic Joint Venture Company for the Lofdal Heavy Rare Earth Project
Published on 07/30/2026 at 23:01, 9 hours 1 minute ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended June 30, 2026 and Management Changes
Published on 07/30/2026 at 23:00, 9 hours 2 minutes ago Eagle Plains Announces Approval of Warrant Expiry Extension
Published on 07/31/2026 at 07:30, 32 minutes ago SURTECO GROUP SE: Sales and earnings within the target corridor; rise in adjusted and reported EBITDA; forecast confirmed
Published on 07/31/2026 at 07:30, 32 minutes ago R. STAHL publishes half-year results – Sales and profitability in line with planning – Forecast for 2026 confirmed
Published on 07/31/2026 at 07:29, 33 minutes ago RBI: Semi-Annual Financial Report 2026 - Consolidated profit (excl. Russia) up 25%
Published on 07/31/2026 at 07:25, 37 minutes ago EQS-Adhoc: UBS AG: UBS AG published its 2Q26 financial report
Published on 07/31/2026 at 07:00, 1 hour 2 minutes ago Medacta Group SA: Medacta reports continued above-market revenue growth of 9.7% in c.c. in H1 2026
Published on 07/30/2026 at 18:15, 13 hours 46 minutes ago Publication of the 2026 half-year financial report
Published on 07/30/2026 at 18:00, 14 hours 2 minutes ago PR ICADE – ACQUISITION OF A CONTROLLING INTEREST IN COMET
